IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $105,889 | +11.0% | 15,041 | -3.6% | 0.00% | +33.3% |
| Q1 2023 | $95,371 | -7.5% | 15,609 | -3.3% | 0.00% | -25.0% |
| Q4 2022 | $103,115 | -41.4% | 16,137 | -12.3% | 0.00% | -50.0% |
| Q3 2022 | $176,000 | -25.4% | 18,394 | -6.5% | 0.01% | -20.0% |
| Q2 2022 | $236,000 | -32.2% | 19,668 | -0.5% | 0.01% | -23.1% |
| Q1 2022 | $348,000 | +17.6% | 19,766 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $296,000 | -43.1% | 19,766 | -0.7% | 0.01% | -52.2% |
| Q3 2021 | $520,000 | +19.0% | 19,896 | +21.4% | 0.02% | +9.5% |
| Q2 2021 | $437,000 | – | 16,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |